174 related articles for article (PubMed ID: 22556374)
41. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
Boccara F
AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
[TBL] [Abstract][Full Text] [Related]
42. [HIV infection and chronic inflammation: is the bacterial translocation the underlying cause?].
Estébanez-Muñoz M; Stella N; Bernardino JI
Med Clin (Barc); 2012 May; 138(15):673-7. PubMed ID: 22364956
[TBL] [Abstract][Full Text] [Related]
43. Circulating LPS and (1→3)-β-D-Glucan: A Folie à Deux Contributing to HIV-Associated Immune Activation.
Ramendra R; Isnard S; Mehraj V; Chen J; Zhang Y; Finkelman M; Routy JP
Front Immunol; 2019; 10():465. PubMed ID: 30967860
[TBL] [Abstract][Full Text] [Related]
44. Cardiovascular Disease and Thrombosis in HIV Infection.
Perkins MV; Joseph SB; Dittmer DP; Mackman N
Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):175-191. PubMed ID: 36453273
[TBL] [Abstract][Full Text] [Related]
45. Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART.
Zicari S; Sessa L; Cotugno N; Ruggiero A; Morrocchi E; Concato C; Rocca S; Zangari P; Manno EC; Palma P
Viruses; 2019 Feb; 11(3):. PubMed ID: 30818749
[TBL] [Abstract][Full Text] [Related]
46. Understanding the Mechanisms of Fibrogenesis in HIV/HCV-Coinfected Patients: Implications for Clinical Practice.
Sacchi P; Cima S; Zuccaro V; Columpsi P; Sarda C; Mariani M; Puoti M; Bruno R
AIDS Rev; 2015; 17(3):159-70. PubMed ID: 26450804
[TBL] [Abstract][Full Text] [Related]
47. [Inflammation and HIV].
Bricaire F; Valantin MA
Bull Acad Natl Med; 2011 Mar; 195(3):531-42; discussion 543-4. PubMed ID: 22292303
[TBL] [Abstract][Full Text] [Related]
48. Persisting inflammation and chronic immune activation but intact cognitive function in HIV-infected patients after long-term treatment with combination antiretroviral therapy.
Pedersen KK; Pedersen M; Gaardbo JC; Ronit A; Hartling HJ; Bruunsgaard H; Gerstoft J; Ullum H; Nielsen SD
J Acquir Immune Defic Syndr; 2013 Jul; 63(3):272-9. PubMed ID: 23392469
[TBL] [Abstract][Full Text] [Related]
49. Assessment of atherosclerotic cardiovascular disease risks between people living with HIV receiving first-line and second-line antiretroviral therapy in a resource-limited setting.
Tiarukkitsagul J; Sungkanuparph S
Int J STD AIDS; 2021 Apr; 32(5):421-426. PubMed ID: 33533302
[TBL] [Abstract][Full Text] [Related]
50. Cardiovascular disease in HIV: traditional and nontraditional risk factors.
Grinspoon SK
Top Antivir Med; 2014; 22(4):676-9. PubMed ID: 25398068
[TBL] [Abstract][Full Text] [Related]
51. Immune-mediated mechanisms in atherosclerosis: prevention and treatment of clinical manifestations.
Niessner A; Goronzy JJ; Weyand CM
Curr Pharm Des; 2007; 13(36):3701-10. PubMed ID: 18220809
[TBL] [Abstract][Full Text] [Related]
52. Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?
Bigeh A; Sanchez A; Maestas C; Gulati M
Trends Cardiovasc Med; 2020 Nov; 30(8):463-469. PubMed ID: 31653485
[TBL] [Abstract][Full Text] [Related]
53. Does choice of antiretroviral drugs matter for inflammation?
Gutierrez MDM; Mateo MG; Vidal F; Domingo P
Expert Rev Clin Pharmacol; 2019 May; 12(5):389-396. PubMed ID: 31017494
[TBL] [Abstract][Full Text] [Related]
54. The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.
Lurain NS; Hanson BA; Hotton AL; Weber KM; Cohen MH; Landay AL
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):134-43. PubMed ID: 26422187
[TBL] [Abstract][Full Text] [Related]
55. HIV and its relationship to insulin resistance and lipid abnormalities.
Non LR; Escota GV; Powderly WG
Transl Res; 2017 May; 183():41-56. PubMed ID: 28068521
[TBL] [Abstract][Full Text] [Related]
56. Age-specific associations between HIV infection and carotid artery intima-media thickness in China: a cross-sectional evaluation of baseline data from the CHART cohort.
Lin H; Ding Y; Ning C; Qiao X; Chen X; Chen X; Shen W; Liu X; Hong Y; He N
Lancet HIV; 2019 Dec; 6(12):e860-e868. PubMed ID: 31635991
[TBL] [Abstract][Full Text] [Related]
57. HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa.
Maponga TG; Andersson MI; van Rensburg CJ; Arends JE; Taljaard J; Preiser W; Glashoff RH
BMC Infect Dis; 2018 May; 18(1):214. PubMed ID: 29739341
[TBL] [Abstract][Full Text] [Related]
58. Shared mechanisms of multimorbidity in COPD, atherosclerosis and type-2 diabetes: the neutrophil as a potential inflammatory target.
Hughes MJ; McGettrick HM; Sapey E
Eur Respir Rev; 2020 Mar; 29(155):. PubMed ID: 32198215
[TBL] [Abstract][Full Text] [Related]
59. [Microbial translocation in HIV infection].
Oleksiuk J; Grzeszczuk A
Pol Merkur Lekarski; 2014 Dec; 37(222):353-5. PubMed ID: 25715577
[TBL] [Abstract][Full Text] [Related]
60. Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy.
Ahmed D; Roy D; Cassol E
Mediators Inflamm; 2018; 2018():6238978. PubMed ID: 30363715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
